Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1171 to 1185 of 1331 results for heart OR cardi* OR arrythmia

  1. The effects of stopping and/or switching drug treatments to control blood glucose levels: In adults with type 2 diabetes, what are the effects of stopping and/or switching drug treatments to control blood glucose levels, and what criteria should inform the decision?

    diabetes control (HbA1c levels), hypoglycaemic risk, weight gain, and cardiovascular morbidity and mortality. In addition, there is...

    Research recommendation
    Published
    16 December 2021

  2. Long-term outcomes associated with blood glucose lowering agents: In adults with type 2 diabetes, what are the long‑term effects of blood glucose lowering therapies such as dipeptidyl peptidase‑4 (DPP‑4) inhibitors, sodium–glucose cotransporter‑2 (SGLT2) inhibitors and meglitinides?

    particularly newer agents in terms of efficacy and adverse events (for example, cardiovascular outcomes). Randomised controlled trials...

    Research recommendation
    Published
    16 December 2021

  3. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    in adults unless contraindicated (adults over 65 or with a history of cardiovascular disease). Although evidence about dosing was very...

    Research recommendation
    Published
    10 February 2020

  4. What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes?

    effects. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    3 May 2024

  5. What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

    fibrillation, osteoporosis, dementia, and death, including death from cardiovascular disease. Although most people with subclinical...

    Research recommendation
    Published
    10 February 2020

  6. What are the long-term outcomes of different management strategies for primary hyperparathyroidism? Which strategies are most cost effective?

    committee agreed that there was no evidence to suggest that surgery modifies cardiovascular disease risk or fracture risk, so these...

    Research recommendation
    Published
    25 October 2019

  7. Current evidence on the safety and efficacy of valve-in-valve transcatheter aortic valve implantation (ViV‑TAVI) for aortic bioprosthetic dysfunction is adequate to support the use of this procedure provided that  standard arrangements   are in place for clinical governance, consent and audit.

    interventional cardiologists experienced in the procedure, cardiac surgeons, an expert in cardiac imaging and,...

    Research recommendation
    Published
    22 June 2023

  8. Blood pressure targets for people with aortic aneurysm: What are the optimal blood pressure targets in adults with hypertension and aortic aneurysm, and does this vary by age?

    the rationale and impact section on blood pressure targets for people with cardiovascular disease. Full details of the evidence and the...

    Research recommendation
    Published
    11 April 2022

  9. Blood pressure targets for people with prior ischaemic or haemorrhagic stroke: What are the optimal blood pressure targets in adults with prior ischaemic or haemorrhagic stroke, and does this vary by age?

    the rationale and impact section on blood pressure targets for people with cardiovascular disease. Full details of the evidence and the...

    Research recommendation
    Published
    11 April 2022

  10. The evidence on percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI raises no major safety concerns other than those associated with the TAVI procedure. However, the evidence on efficacy for preventing TAVI-related stroke is inconclusive. Therefore, this procedure should only be used with  special arrangements   for clinical governance, consent, and audit or research.

    endovascular interventions. Centres doing this procedure should have both cardiac and vascular surgical support for the emergency...

    Research recommendation
    Published
    15 November 2019

  11. Needs assessment:- In the UK, how prevalent is coexisting severe mental illness with substance misuse and what are the physical health, social care, housing or other support needs of people with this diagnosis?

    This includes prevalence of coexisting physical conditions such as cardiovascular, respiratory or infectious diseases and social care...

    Research recommendation
    Published
    10 February 2017

  12. What is the optimal ratio of non-nitrogen energy to nitrogen in parenteral nutrition for preterm and term babies?

    associated with metabolic ill health in later life (for example, risk of cardiovascular disease, diabetes and obesity-related...

    Research recommendation
    Published
    17 March 2020

  13. Management of stable angina in people with evidence of ischaemia on non-invasive functional testing:- Do people with stable angina and evidence of reversible ischaemia on noninvasive functional testing who are on optimal drug treatment benefit from routine coronary angiography with a view to revascularisation?

    relevant for people who have responded adequately (for example Canadian Cardiovascular Class 1 or 2) to optimal drug treatment and in...

    Research recommendation
    Published
    9 June 2015

  14. Ovarian cancer: identifying and managing familial and genetic risk (NG241)

    This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults.

    NICE guideline
    Published
    21 March 2024
    View recommendations

    Sections for NG241

  15. Rapid tests for group A streptococcal infections in people with a sore throat (HTG531)

    Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat.

    HealthTech guidance
    Published
    13 November 2019
    View recommendations

    Sections for HTG531